Results 71 to 80 of about 274,562 (162)

Effects of maternal high fat diet and pharmacological intervention on the developmental origins of metabolic & cardiovascular disease

, 2011
A high fat (HF) diet leads to hypercholesterolemia and predisposes the individual to developing cardiovascular disease (CVD). We hypothesised that mother‘s HF diet before and during pregnancy and lactation can also influence predisposition to CVD in ...
Elahi, Maqsood M.
core  

Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome

Lipids in Health and Disease
Background Cardiovascular-kidney-metabolic (CKM) syndrome is characterized as a systemic disease resulting from the pathophysiological interplay among metabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD).
Jiao Tang, Zhehao Xu, Li Ren, Jiahua Xu, Xin Chen, Yian Jin, Ruiyun Liang, Huanji Zhang   +7 more
doaj   +1 more source

Epicardial Fat Tissue Thickness Correlates with Endothelial Dysfunction and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome

, 2010
Background: Epicardial adipose tissue has shown to be related to cardiovascular risk. The aim of this study is to investigate the relationship between epicardial adiposity and endothelial function in metabolic syndrome.
YAVUZ, DİLEK, ÜSTAY, ÖZLEM
core   +1 more source

Estimated glucose disposal rate and mortality risk in cardiovascular–kidney–metabolic syndrome: a population-based study

BMC Endocrine Disorders
Background Cardiovascular–kidney–metabolic (CKM) syndrome is a systemic disorder characterized by the interrelated dysfunction of metabolic abnormalities, chronic kidney disease, and cardiovascular injury, significantly increasing the risk of ...
Zheng Zhang, Chao Fu, Yiyi Chai, Yanrong Gu, Xiaomin Wu, Dou Zhu, Ping Lin, Bo Yu, Ling Li   +8 more
doaj   +1 more source

Nutrients and pharmacological management of Metabolic syndrome

, 2021
Metabolic syndrome is a public health problem defined by a cluster of interconnected components that increase the risk of cardiovascular atherosclerotic diseases and T2DM.
Ghim, Nayoung
core  

Laser therapy in metabolic syndrome-related kidney injury

, 2013
Metabolic syndrome is characterized by hyperglycemia, hypertension, dyslipidemia and obesity. Diabetes and hypertension are the main causes of chronic end-stage kidney disease in humans.
Joeken, Stephan, Ucero Herrería, Álvaro Conrado, Sabban, Bettina, Carrasco, Susana, Ortiz, Alberto, Benito Martín, Alberto   +5 more
core   +1 more source

Exercise in CKM syndrome progression: a stage-specific approach to cardiovascular, metabolic, and renal health

Cardiovascular Diabetology
Cardiovascular-Kidney-Metabolic (CKM) syndrome progresses through distinct stages, from early metabolic risk factors to advanced cardiovascular disease and kidney dysfunction. Across these stages, exercise remains a central yet underutilized intervention,
Zacharias Papadakis
doaj   +1 more source

Differential Association of Regional Adipose Tissue Deposit with Cardiovascular-Kidney-Metabolic Syndrome

Cardiorenal Medicine
Introduction: Cardiovascular-kidney-metabolic (CKM) syndrome is a condition characterized by the interplay between cardiovascular disease, kidney disease, diabetes, and obesity, resulting in adverse health outcomes.
In-Jeong Cho, Sang-Eun Lee, Wook Bum Pyun   +2 more
doaj   +1 more source

The impact of lifestyle, measured with the HLPCQ questionnaire on the prevalence of metabolic syndrome in Poland: a multicenter study

Scientific Reports
Metabolic syndrome is one of the most common health problems for people around the world. The aim of our study was to assess the prevalence of metabolic syndrome among adults without prior diagnosis of cardiovascular disease, diabetes, and chronic kidney
Mateusz Babicki, Karolina Kłoda, Justyna Ledwoch, Sandra Janiak, Filip Krzyżanowski, Tomasz Zieliński, Patrycja Grabska, Dominik Gajowiak, Wojciech Malchrzak, Agnieszka Mastalerz-Migas   +9 more
doaj   +1 more source

Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Cardiovascular‐kidney‐metabolic (CKM) syndrome is a recently proposed condition encompassing metabolic dysfunction, chronic kidney disease, and cardiovascular diseases including coronary artery disease (CAD).
Wataru Kawaharata, Marenao Tanaka, Tatsuya Sato, Yukinori Akiyama, Itaru Hosaka, Hiroki Aida, Rie Matsumori, Kei Nakata, Keitaro Nishizawa, Toru Suzuki, Hidemichi Kouzu, Nagisa Hanawa, Masato Furuhashi   +12 more
doaj   +1 more source